Neurology

Jim Cassidy, MD, PhD, chief medical officer at SpringWorks Therapeutics, talked about how the prioritization…

Post Content: Source: Neurology Read More

NeuroQuant previously received clearance from the FDA as a medical device intended for automatic labeling,…

AXS-07 has been supported by data from 2 major phase 3 trials in which treatment…

Stuart Isaacson, MD, Rajesh Pahwa, MD, and Jennifer Goldman, MD discuss optimizing PD treatment with…

The director of neurology and neuromuscular medicine at the Children’s Hospital of the King’s Daughters…

The medical director of the Toronto Memory Program at the University of Toronto provided an…

Tolebrutinib, a brain-penetrant BTK inhibitor, achieved the primary endpoint in the HERCULES study, significantly reducing…

In a 3-month trial at two primary care sites, neurology referrals decreased by 77%, and…

Here's some of what is coming soon to NeurologyLive® this week.: Source: Neurology Read More